Skip to content

PROKTIS-M végbélkúp

by FARMA-DERMA S.r.l. Italy EUDAMED

Ref 1117

EMDN G05

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number803259587TF02ED Basic UDI-DIDate4 Aug 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • EPT 0477.MDR.22/5022 Issued

    Quality management system EU MDR

    Notified body
    Notified body 0477
    Issued
    20 Dec 2022
    Expires
    19 Dec 2027

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Cicatridina supposte
Model / Reference
1117
Primary DI / UDI-DI
08032595872924
Basic UDI-DI
803259587TF02ED
EMDN Code
G05 Topical anorectal administered gastro-intestinal system devices
Device Class
Class IIb
Market of Registration
Hungary

Manufacturer details

EUDAMED SRN
IT-MF-000020737

Other devices from FARMA-DERMA S.r.l.

See all devices from FARMA-DERMA S.r.l. →

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 0210614c-e26d-49a4-877d-0b7de1d7f24c 61 fields · synced 22 Oct 2026